Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas
(Q30433950)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P304) |
97-109
|
||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||
| (P433) |
1-2
|
||||||||||||||||||||||||
| (P478) |
289
|
||||||||||||||||||||||||
| (P577) |
Tuesday, June 1, 2004
|
||||||||||||||||||||||||
| (P921) |
(Q715347)
(Q29496)
(Q1088156)
(Q412323)
|
||||||||||||||||||||||||
| (P1433) |
(Q15755939)
|
||||||||||||||||||||||||
| (P1476) |
"Three new assays for rituximab based on its immunological activity or antigenic properties: analyses of sera and plasmas of RTX-treated patients with chronic lymphocytic leukemia and other B cell lymphomas" (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Paul V Beum
Adam D Kennedy
Ronald P Taylor
|
other details